Stock screener

TARS

Conviction 72HealthcareScan · Thu, Sep 24, 2026

Tarsus Pharmaceuticals, Inc. (TARS) closed at $75.87 (+2.13%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 50, RS Rating 89, -16.4% from its 52-week high, -6.1% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

TARS$75.87+2.13%
ResistanceSupportVol 14Insider sell
63 bars
3
7
Vol MA14 733.31K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Tarsus Pharmaceuticals, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.tarsusrx.com ↗
Price75.87
Change+2.13%
Gap+1.43%
Rel volume0.70×
Avg volume784.59K
Avg $ vol63.09M
SMA 2078.84
SMA 5070.24
SMA 20068.69
Price vs 50+8.01%
Price vs 200+10.45%
MA stackbullish
50/200 crossgolden · 3d
Supertrenddown · 85.07
RSI (14)50
MACD hist-1.20
MACD crossbear · 8d
Stoch %K / %D10 / 9
ADX (14)29
+DI / −DI22 / 20
RSI divergence—
MACD divergence—
ATR %4.16%
ADR %4.29%
52w high90.78
52w low55.26
From 52w high-16.42%
Above 52w low+37.30%
New 52w highNo
SqueezeOff
Bollinger width24.02%
%B0.34
Donchian pos29.03%
Donchian high91.53
Donchian low69.47
AVWAP (52w high)81.83
vs AVWAP high-7.28%
AVWAP (52w low)69.41
vs AVWAP low+9.30%
OBV trendFlat
Chaikin MF (20)0.04
Today vs 20d0.70×
Avg vol (14d)733.31K
Avg vol (20d)784.59K
Avg $ vol (20d)63.09M
Market cap3.33B
RS Rating89 / 99
RS 3m (vs SPY)+13.43%
RS 6m (vs SPY)-3.51%
RS line new highNo
Trend template6/8
Technical rank78.2
1 week-4.00%
1 month+6.19%
3 months+17.92%
6 months+13.31%
1 year+36.38%
YTD-6.07%
P/E-50.13
P/B9.60
P/S7.38
P/FCF-149.23
EPS-1.59
Div yield—
ROE-19.16%
ROA-10.87%
Debt/Eq0.21
Current3.20
EV/EBITDA—
Gross margin—
Net margin-14.72%
Rev growth146.71%
EPS growth42.52%
Price target100.11
Target upside31.95%
Analyst ratingBuy
Institutional111.23%
Ent. value3.2B
Revenue173.91M
Net income-18.55M
Gross profit—
Free cash flow-22.31M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out43.02M
Employees370
ListedFri, Oct 16, 2020
Free float36.67M
Float %86.2%
Short interest6.01M
Days to cover9.8d
Short volume44.6%
Squeeze score61 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.43 vs −$0.21
Last surprise-104.8% miss
Setup gradeB
Conviction72 / 100
Pattern quality—
Tech rank78.2 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance82.77
Support62.62
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TARS

All disclosures →
No recent disclosed trades by Congress in TARS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TARS · open-market 4 sells

InsiderSideShares
PYOTT DAVID E I
Director · Common Stock · 2026-09-15
Exercise201
YARNO WENDY L
Director · Restricted Stock Units · 2026-09-15
Exercise302
LINK WILLIAM J PHD
Director · Common Stock · 2026-09-15
Exercise201
LINK WILLIAM J PHD
Director · Common Stock · 2026-09-15
Sell11.68K
LINK WILLIAM J PHD
Director · Common Stock · 2026-09-15
Sell759
LINK WILLIAM J PHD
Director · Common Stock · 2026-09-15
Sell66
LINK WILLIAM J PHD
Director · Restricted Stock Units · 2026-09-15
Exercise201
PYOTT DAVID E I
Director · Restricted Stock Units · 2026-09-15
Exercise201
YARNO WENDY L
Director · Common Stock · 2026-09-15
Exercise302
Azamian Bobak R.
President/CEO and Board Chair · Common Stock · 2026-09-04
Sell7.1K

SEC filings

EDGAR filings in TARS · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.